Tokyo, Japan – February 17, 2021 – LPIXEL Inc., a leader in image analysis and processing in life science and medical research, announced today its achievement in gaining EN ISO 13485:2016 Medical Device Certification. It indicates that the LPIXEL’s Management System meets the most current regulatory requirements specific to the design, manufacture, and distribution of software used for analysis of medical diagnostic images.
EIRL is the collective name given to LPIXEL’s AI medical image diagnostic support technology. LPIXEL aims to provide solutions that enable a faster and more accurate diagnosis by implementing its unique algorithms to analyze medical big data, such as brain MRI, chest X-rays, and colonoscopy. For more information, please visit https://eirl.ai/en/
LPIXEL is a leader in advanced image analysis and processing technology encompassing the life science field. Founded in March 2014, LPIXEL is dedicated to offering research facilities, top-tier image analysis technologies and medical diagnosis technologies, both of which adopt advanced AI technology. LPIXEL revolves around business such as its medical image analysis software, “EIRL,” and its AI-based image analysis service, “IMACEL.”
For more information, please visit https://lpixel.net/en/